Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
View ORCID ProfileErik Jue, View ORCID ProfileRustem F. Ismagilov
doi: https://doi.org/10.1101/2020.04.28.20077602
Erik Jue
aDivision of Biology and Biological Engineering
Rustem F. Ismagilov
aDivision of Biology and Biological Engineering
bDivision of Chemistry and Chemical Engineering
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data will be made available at CaltechDATA upon publication.
Posted May 04, 2020.
Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
Erik Jue, Rustem F. Ismagilov
medRxiv 2020.04.28.20077602; doi: https://doi.org/10.1101/2020.04.28.20077602
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (655)
- Anesthesia (175)
- Cardiovascular Medicine (2548)
- Dermatology (214)
- Emergency Medicine (387)
- Epidemiology (12034)
- Forensic Medicine (10)
- Gastroenterology (725)
- Genetic and Genomic Medicine (3950)
- Geriatric Medicine (372)
- Health Economics (661)
- Health Informatics (2553)
- Health Policy (984)
- Hematology (354)
- HIV/AIDS (817)
- Medical Education (391)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3713)
- Nursing (205)
- Nutrition (553)
- Oncology (1930)
- Ophthalmology (563)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (245)
- Palliative Medicine (71)
- Pathology (468)
- Pediatrics (1083)
- Primary Care Research (440)
- Public and Global Health (6382)
- Radiology and Imaging (1348)
- Respiratory Medicine (853)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (184)
- Urology (160)